Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 67 (PPIAP67) is designated as a pseudogene related to the parental gene *peptidylprolyl isomerase A* (PPIA)[2][3]. Pseudogenes are DNA sequences similar to known genes but have lost their protein-coding potential due to mutations; they do not encode functional proteins and are not considered direct therapeutic targets such as receptors, enzymes, or transporters. While some pseudogenes may act as non-coding RNAs that regulate the expression of their parental gene or serve as competing endogenous RNAs in specific contexts (e.g., PPIAP22[3], PPIAP43[2]), there is currently no evidence that PPIAP67 has functional biological activity, disease associations, or drug interactions. There are no approved drugs or known mechanisms of action involving PPIAP67. Therefore, PPIAP67 is not considered a classical molecular target. Key clarifications: - The "is_target" field is **false** for PPIAP67, as it is not a functional receptor, enzyme, or therapeutic target. - The "is_incorrect" field is **true**, as PPIAP67 is sometimes mistakenly listed among targets due to confusion with the functional parent gene *PPIA* (cyclophilin A)[1][2][3]. If you are seeking a therapeutic target, you should refer to *peptidylprolyl isomerase A* (PPIA or cyclophilin A), not its pseudogenes. - For all functional and disease-relevant information, consult literature on *peptidylprolyl isomerase A* (PPIA), not its pseudogenes except in rare regulatory RNA contexts, which do not apply to PPIAP67 based on current data[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 67 (PPIAP67).